000 04402namaa22004211i 4500
003 OSt
005 20250223033352.0
008 241223s2023 |||a|||f |m|| 000 0 eng d
040 _aEG-GICUC
_beng
_cEG-GICUC
_dEG-GICUC
_erda
041 0 _aeng
_beng
_bara
049 _aDeposit
082 0 4 _a616.07
092 _a616.07
_221
097 _aM.Sc
099 _aCai01.11.07.M.Sc.2023.Om.S.
100 0 _aOmnia Attia Saad,
_epreparation.
245 1 0 _aStudy of the association between SIRT1 single nucleotide gene variant and corticosteroid response in Egyptian pediatric patients with primary immune thrombocytopenia /
_cBy Omnia Attia Saad; Supervised By Prof. Dr. Nevine Mohamed Bahaa Eldin Fouad, Asst. Prof. Marwa Abd Elhady Abd Elsamad, Dr. Doaa Salah Mahmoud
246 1 5 _aفى الاطفال SIRT 1 دراسة ارتباط تعدد الجينى لجين المصرين المصابين بمرض نقص الصفائح الدموية المناعى ومدي الاستجابه للعلاج بالكورتيزون /
264 0 _c2023.
300 _a93 pages :
_billustrations ;
_c25 cm. +
_eCD.
336 _atext
_2rda content
337 _aUnmediated
_2rdamedia
338 _avolume
_2rdacarrier
502 _aThesis (M.Sc.) -Cairo University, 2023.
504 _aBibliography: pages 76-90.
520 _aBackground: Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by decreased platelet count. While corticosteroids are a useful first- line therapy for ITP patients, their long-term effectiveness is limited, and the determinants of corticosteroid sensitivity in ITP patients remain largely unknown. Silent information regulator 1 (SIRT1) is a histone deacetylase of nicotinamide adenine dinucleotide (NAD+), which mainly exists in the nucleus, and is a member of a family of well-studied mammalian sirtuins. SIRT1 interacts with protein substrates in a variety of signaling pathways (such as Wnt and Notch), participates in the regulation of most of the body’s physiological functions, and plays a central regulatory role in cell proliferation, differentiation, senescence, apoptosis, and metabolism.it is also related to the anti-inflammatory effect of corticosteroids. Aim of the Work: The present work was done to study the prevalence and role of SIRT1 SNP rs12778366 in ITP susceptibility and corticosteroids sensitivity. Participants and Methods: Sixty patients with ITP as well as 60 age and sex- matched normal healthy controls were included. SIRT1 rs12778366 SNP was determined by allelic discrimination Taqman real-time PCR. Results: Our study revealed that SIRT1 rs12778366 variants among ITP patients were found to be the wild type T/T (81.7%), the heterozygous T/C (16.7%) and the homozygous C/C genotype (1.7%), while among the control group were the wild type T/T (90%), the heterozygous T/C (10%) and non were in the homozygous C/C with no statistically significant difference between the 2 groups (p ˃0.05) and that SIRT1 rs12778366 variants had no role as a risk factor of ITP susceptibility. Regarding sensitivity to corticosteroids, patients who were sensitive to steroids were found to be the wild type T/T (90%), the heterozygous T/C (10%) and non were in the homozygous C/C, while ITP patients who were resistant to corticosteroids, the wild type T/T (73.3%), the heterozygous T/C (23.3%) and the homozygous C/C (3.3%) with no significant difference between the 2 groups (p ˃0.05) and that SIRT1 rs12778366 variants had no impact on prognosis or treatment outcome. Conclusion: SIRT1 rs12778366 had no role in ITP susceptibility, disease severity or corticosteroid sensitivity.
530 _aIssued also as CD
546 _aText in English and abstract in Arabic & English.
650 7 _aPathology
_2qrmak
653 0 _aImmune thrombocytopenic purpura
_aSIRT1 rs12778366
_agene variants
_aTaqman RT-PCR
700 0 _aNevine Mohamed Bahaa Eldin Fouad
_ethesis advisor.
700 0 _aMarwa Abd Elhady Abd Elsamad
_ethesis advisor.
700 0 _aDoaa Salah Mahmoud
_ethesis advisor.
900 _b01-01-2023
_cNevine Mohamed Bahaa Eldin Fouad
_cMarwa Abd Elhady Abd Elsamad
_cDoaa Salah Mahmoud
_UCairo University
_FFaculty of Medicine
_DDepartment of Clinical and Chemical Pathology
905 _aNourhan
_eHuda
942 _2ddc
_cTH
_e21
_n0
999 _c169673